Allarity Therapeutics, Inc. Depreciation
Allarity Therapeutics, Inc. (ALLR) reported Depreciation of $58.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2022-11-14
- Allarity Therapeutics, Inc. depreciation for the quarter ending 2022-09-30 was $11.00K, a 50.00% decline year-over-year.
- Allarity Therapeutics, Inc. depreciation for the quarter ending 2022-06-30 was $24.00K.
- Allarity Therapeutics, Inc. depreciation for the quarter ending 2022-03-31 was $23.00K, a 58.93% decline year-over-year.
- Allarity Therapeutics, Inc. depreciation for the quarter ending 2021-12-31 was -$78.00K.
- Allarity Therapeutics, Inc. depreciation for fiscal 2021 was $12.00K, a 42.86% decline from fiscal 2020.
- Allarity Therapeutics, Inc. depreciation for fiscal 2020 was $21.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2022-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $35.00K derived: sum of 2 quarters · filed 2022-11-14 | $58.00K 10-Q · filed 2022-11-14 | -$20.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | $47.00K 10-Q · filed 2022-10-07 | -$31.00K derived: sum of 3 quarters · filed 2022-10-07 | -$9.00K derived: sum of 4 quarters · filed 2022-10-07 |
| 2022-03-31 | $23.00K 10-Q · filed 2022-05-27 | -$55.00K derived: sum of 2 quarters · filed 2022-05-27 | -$33.00K derived: sum of 3 quarters · filed 2022-05-27 | -$36.00K derived: sum of 4 quarters · filed 2022-10-07 |
| 2021-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-17 | -$56.00K derived: sum of 2 quarters · filed 2022-05-17 | -$59.00K derived: sum of 3 quarters · filed 2022-10-07 | $12.00K 10-K · filed 2022-05-17 |
| 2021-09-30 | $22.00K 10-Q/A · filed 2022-05-17 | $19.00K derived: sum of 2 quarters · filed 2022-10-07 | $90.00K 10-Q · filed 2022-11-14 | -$14.00K derived: sum of 4 quarters · filed 2022-10-07 |
| 2021-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | $53.00K 10-Q · filed 2022-10-07 | -$36.00K derived: sum of 3 quarters · filed 2022-10-07 | $2.00K derived: sum of 4 quarters · filed 2022-10-07 |
| 2021-03-31 | $56.00K 10-Q · filed 2022-05-27 | -$33.00K derived: sum of 2 quarters · filed 2022-05-27 | $5.00K derived: sum of 3 quarters · filed 2022-05-27 | |
| 2020-12-31 | -$89.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | -$51.00K derived: sum of 2 quarters · filed 2022-05-17 | $21.00K 10-K · filed 2022-05-17 | |
| 2020-09-30 | $38.00K 10-Q/A · filed 2022-05-17 | $110.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |